dalbavancin(达巴万星)是一类长效的新型脂糖肽类抗生素,可以每周给药1次,对引起皮肤软组织感染的常见病原菌包括许多耐药菌有很高的抗菌活性,在美国已被批准用于治疗革兰阳性菌引起的皮肤软组织感染。作者等报道2002—2007年从33个国家收集81673株葡萄球菌、肠球菌和链球菌,测 dalbavancin (dalbavancin) is a long-acting novel lipopeptide peptide antibiotics, can be administered once a week, the common pathogenic bacteria causing skin and soft tissue infections, including many resistant bacteria have a high antibacterial activity in the United States Has been approved for the treatment of Gram-positive bacteria caused by skin and soft tissue infections. The authors reported that 81,673 strains of staphylococci, enterococci and streptococci were collected from 33 countries from 2002 to 2007 and measured